Emerging Technology Partners
North America, California, United States, San Francisco
Description
Emerging Technology Partners is a life sciences focused investment firm.
Investor Profile
Emerging Technology Partners has made 22 investments, with 1 in the past 12 months and 27% as lead.
Stage Focus
- Series A (32%)
- Series Unknown (18%)
- Series B (18%)
- Series C (14%)
- Seed (9%)
- Post Ipo Equity (9%)
Country Focus
- United States (68%)
- China (23%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
- Hong Kong (5%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
- Switzerland (5%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Genetics
- Pharmaceutical
- Biopharma
- Manufacturing
- Health Diagnostics
- Retail
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
